Arbutus Biopharma Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TWO SEAS CAPITAL LP | 08/12/2026 | 19.10 M | $91.66 M | 2.90% | 9.85% |
| MORGAN STANLEY | 08/13/2026 | 17.70 M | $84.95 M | -31.64% | 9.13% |
| WHITEFORT CAPITAL MANAGEMENT, LP | 08/14/2026 | 15.79 M | $75.81 M | 5.78% | 8.15% |
| BLACKROCK, INC. | 08/07/2026 | 13.77 M | $66.08 M | 6.16% | 7.10% |
| STATE STREET CORP | 08/07/2026 | 7.87 M | $37.77 M | 24.07% | 4.06% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/14/2026 | 7.53 M | $36.16 M | 13.68% | 3.89% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 7.01 M | $33.65 M | 4.81% | 3.62% |
| BARCLAYS PLC | 08/14/2026 | 4.21 M | $20.20 M | -2.51% | 2.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 4.12 M | $19.77 M | 9.17% | 2.13% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 3.51 M | $16.83 M | 218.67% | 1.81% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 2.65 M | $12.70 M | 57.17% | 1.37% |
| BLACKBARN CAPITAL PARTNERS LP | 08/14/2026 | 2.50 M | $12.00 M | 0.00% | 1.29% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 2.47 M | $11.84 M | 2.70% | 1.27% |
| WOODLINE PARTNERS LP | 08/14/2026 | 2.28 M | $10.95 M | 13.52% | 1.18% |
| JEFFERIES FINANCIAL GROUP INC. | 08/17/2026 | 1.71 M | $8.22 M | -9.63% | 0.88% |
| NOMURA HOLDINGS INC | 08/14/2026 | 1.64 M | $7.86 M | 100.00% | 0.84% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.54 M | $7.40 M | 10.74% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.43 M | $6.87 M | 2.15% | 0.74% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.43 M | $6.87 M | 100.00% | 0.74% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.42 M | $6.81 M | 11.05% | 0.73% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 1.35 M | $6.47 M | -0.02% | 0.70% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.27 M | $6.09 M | -59.53% | 0.65% |
| DELTROIT ASSET MANAGEMENT (UK) LLP | 08/14/2026 | 1.20 M | $5.76 M | 50.00% | 0.62% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.14 M | $5.45 M | 6.80% | 0.59% |
| CITIGROUP INC | 08/03/2026 | 879.24 K | $4.22 M | -2.14% | 0.45% |
| BANK OF MONTREAL /CAN/ | 08/12/2026 | 777.94 K | $3.73 M | -0.62% | 0.40% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 650.70 K | $3.12 M | 100.00% | 0.34% |
| MACKENZIE FINANCIAL CORP | 08/13/2026 | 613.81 K | $2.95 M | 100.00% | 0.32% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/13/2026 | 602.01 K | $2.89 M | 100.00% | 0.31% |
| JUPITER TOPCO LLC | 08/14/2026 | 597.42 K | $2.87 M | 100.00% | 0.31% |
| WESTERN STANDARD LLC | 08/10/2026 | 542.79 K | $2.61 M | 4.06% | 0.28% |
| RANGELEY CAPITAL, LLC | 08/14/2026 | 500.00 K | $2.40 M | 0.00% | 0.26% |
| NUVEEN, LLC | 08/11/2026 | 496.61 K | $2.38 M | 91.73% | 0.26% |
| MAN GROUP PLC | 08/14/2026 | 473.47 K | $2.27 M | 100.00% | 0.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 461.65 K | $2.22 M | 4.70% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 454.12 K | $2.18 M | 19.70% | 0.23% |
| CENTERBOOK PARTNERS LP | 08/11/2026 | 445.15 K | $2.14 M | 100.00% | 0.23% |
| FREESTONE CAPITAL HOLDINGS, LLC | 07/31/2026 | 442.50 K | $2.12 M | 0.00% | 0.23% |
| CITADEL ADVISORS LLC | 08/14/2026 | 404.70 K | $1.94 M | -40.23% | 0.21% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2026 | 385.30 K | $1.85 M | -1.99% | 0.20% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 381.86 K | $1.83 M | 166.66% | 0.20% |
| SWISS NATIONAL BANK | 08/11/2026 | 286.50 K | $1.38 M | 1.09% | 0.15% |
| LEDGEWOOD WEALTH ADVISORS, LLC | 07/08/2026 | 278.44 K | $1.34 M | 0.00% | 0.14% |
| FMR LLC | 08/13/2026 | 267.19 K | $1.28 M | 84.11% | 0.14% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 263.69 K | $1.27 M | 1,301.09% | 0.14% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 261.05 K | $1.25 M | -68.86% | 0.13% |
| CARRERA CAPITAL ADVISORS | 08/03/2026 | 257.17 K | $1.23 M | 1.99% | 0.13% |
| QUINN OPPORTUNITY PARTNERS LLC | 08/14/2026 | 255.21 K | $1.23 M | -50.40% | 0.13% |
| INVESCO LTD. | 08/14/2026 | 250.91 K | $1.20 M | 1.20% | 0.13% |
| UBS GROUP AG | 08/13/2026 | 249.21 K | $1.20 M | -31.62% | 0.13% |
Arbutus Biopharma Corp institutional Ownership - FAQ's
During the previous two years, 238 institutional investors and hedge funds held shares of Arbutus Biopharma Corp. The most heavily invested institutionals were:
Two Seas Capital LP: 19.1 M
MORGAN STANLEY: 17.7 M
Whitefort Capital Management, LP: 15.79 M
BlackRock, Inc.: 13.77 M
STATE STREET CORP: 7.87 M
Rubric Capital Management LP: 7.53 M
73.19% of Arbutus Biopharma Corp stock is owned by institutional investors.
Institutional investors have bought a total of 166.49 M shares in the last 24 months. This purchase volume represents approximately $785.84 M in transactions.